WBC | 3,400 | /mm3
| T-bil | 3.14 | mg/dl |
RBC | 456×104
| /mm3
| D-Bil | 1.54 | mg/dl |
Hb | 14.3 | g/dl | BUN | 16 | mg/ dl |
Ht | 41.4 | % | Cre | 0.42 | mg/dl |
Plt | 3.8 ×104
| /mm3
| CRP | 0.67 | mg/mi |
T-P | 6.5 | g/d | PT-% | 44.2 | % |
Alb | 3.5 | g/cl | APTT | 34.6 | sec |
CPK | 36 | IU/L | PT-INR | 1.50 | |
AST | 956 | IU/L | Fib | 168 | mg/dl |
ALT | 584 | IU/L | FDP | 38.4 | μ/ml |
ALP | 779 | IU/L | D-dimer | 36.3 | μ/ml |
LDH | 1581 | IU/L | EBV-DNA | 12x102
| copies/1O6WBC |
r-GTP | 583 | IUL | CMV-antigen | (−) | |
-
WBC white blood cell, RCB red blood cell, Hb hemoglobin, Ht hematocrit, Plt platelet count, T-P total protain, Alb serum albumin, CPK cretine phosphokinase, AST aspartate transaminase, ALT alanine amino transaminase, ALP alkaline phosphatase, LDH lactate dehydrogenese, r-GTP γ-glutamyltranspeptidase, T-bil total-bilirubin, D-Bil direct bilirubin, BUN blood urea nitrogen, Cre cretinine, CRP c-creative protain, PT prothrombin time, APTT activated partial trhomboplastin time, PT-INR prothrombin time-international normalized ratio, Fib fibrinogen, FDP fibrin degradetion product, EBV Epstein-Barr virus, CMV cytomegalovirus
- EBV-DNA 12x102 copies/1O6WBC ⇒ EBV-DNA 12x102 copies/106 WBC
